P-21 5 mg, glass vial, crimp seal, flip-top cap, California Standard Peptides label

Research peptides

P-21

P-21 (also written P021) is a small synthetic peptidergic compound, Ac-DGGL(A)G-NH2, derived from the active region of ciliary neurotrophic factor (CNTF) and carrying an adamantylated glycine. It was designed by Iqbal and colleagues in New York.

5 mgCS-P21-5$120.00
Choose a size and add to cart →
Container
Glass vial, crimp seal, flip-top cap
Storage
-20 °C, desiccated
Paperwork
Lot certificate (HPLC + mass spec) shown before you pay

Lot certificates

You’ll see American Peptides on the lab’s copy. They’re our supplier.

  • 5 mg, lot P21-5-0318: 99.80% purity (RP-HPLC), 5.25 mg measured, identity confirmed by mass spec. Issued 2026-06-17 by Bioviridian Inc.. Verify certificate COA4866

Our vials are filled from lots made by our supplier, American Peptides, and tested by Bioviridian Inc.The laboratory’s original certificate lists American Peptides as the vendor. Look up the code at bioviridians.com to check it.

What researchers study it for

  • Alzheimer-type pathology in transgenic mice
  • Cognitive aging in rats
  • Hippocampal neurogenesis and synaptic plasticity
  • Down syndrome and CDKL5 deficiency models

How it is thought to work

The proposed mechanism, reported by the developing group, is inhibition of leukemia inhibitory factor (LIF) signaling and increased brain-derived neurotrophic factor (BDNF) expression, with a resulting decrease in GSK-3beta activity. It has not been examined in humans. A 2024 study in CDKL5-deficient mice found effects in cultured cells but no BDNF increase in vivo and limited behavioral benefit.

Where the research stands

Preclinical research. Published work is limited to cell, mouse and rat studies, nearly all involving one research group. No human trial of this compound was found on ClinicalTrials.gov, and it is not an approved medicine.

Sources

  1. Kazim SF, et al. (2014). Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease. Neurobiology of Disease.
  2. Bolognin S, et al. (2014). Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound. Neurobiology of Aging.
  3. Kazim SF, Iqbal K. (2016). Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease. Molecular Neurodegeneration.
  4. Mottolese N, et al. (2024). Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder. Journal of Neurodevelopmental Disorders.

For laboratory research use only. Not a drug, food, supplement or cosmetic; not for human or veterinary use. Nothing on this page is medical advice or a usage guide.

California Standard Peptides

Your cart

0 items · free shipping over $200.00

Your cart is empty.

Buy 2 of a vial and save 10%, 3 and save 15%. Research sets are 15% off, and shipping is free over $200.00.

First order

20% off your first order.

Join the list for first word on new lots, restocks and member pricing. Your code arrives by email and applies by itself at checkout.

One code per email, for your first order. By signing up you agree to get emails from us. Unsubscribe anytime.

For laboratory research use only. 21+.